SlideShare una empresa de Scribd logo
1 de 31
Benha University Hospital, Egypt
Email:elnashar1953@yahoo.com
Aboubakr Elnashar
Aboubakr Elnashar
•While there is a useful staging system for
puberty (Tanner/Marshall system),
a similar staging system for late
reproductive function has not been
developed.
•Confusion & duplication in the
nomenclature of the reproductive aging e.g.
climactric, perimenopause
Aboubakr Elnashar
•The American Society for Reproductive
Medicine (ASRM)
•The National Institute on Aging (NIA)
•The North American Menopause Society
(NAMS)
Cosponsored a workshop to
•develop a relevant & useful staging system
•revise the nomenclature
Aboubakr Elnashar
Definition
Aging:
The natural progression of changes in structure and
function that occur with the passage of time in the
absence of known disease.
Reproductive aging:
•A natural process that begins at birth and proceeds as
a continuum.
•It is a process and not an event, and the end
(menopause) is much easier to define than the
beginning.
Chronological age is a very poor indicator of
reproductive aging. Aboubakr Elnashar
Etiology
•Oocyte depletion in the ovary.
•Reproductive aging consists of a steady loss of
oocytes through atresia or ovulation, which does not
necessarily occur at a constant rate.
•The relatively wide age range (42–58 years) for
menopause in normal women indicate that either
- Wide variation in number of follicles at birth or
-Wide variation in the rate of oocyte loss
Aboubakr Elnashar
The workshop concentrated on developing a staging
system for all healthy women who age spontaneously
to a natural menopause.
The purpose of a staging system
To identify what point a given woman has reached in
the process of reproductive aging.
Aboubakr Elnashar
The anchor for the staging system
is the final menstrual period (FMP).
The staging system has 7 stages; 5
precede and 2 follow the final menstrual period.
Stages -5 to -3 encompass the reproductive interval;
Stages -2 and -1 are the menopausal transition; and
Stages +1 and +2 are the postmenopause.
Aboubakr Elnashar
Aboubakr Elnashar
Aboubakr Elnashar
There is no demarcation between stages -5 to -3, since
fertility increases & decreases gradually over many
years.
Menstrual cycles:
After menarche (entry into stage -5) it usually takes
several years for regular menstrual cycles to become
established.
Menstrual periods should then occur every 21 to 35
days for a number of years (stages -4 & -3).
Aboubakr Elnashar
Fertility:
•A woman’s peak fertility occurs in her mid- to late
twenties, after which it progressively decreases until
menopause (stage -4 to -1).
•Loss of fertility is the first sign of reproductive aging
that precedes the monotropic increase in FSH and
changes in menstrual cyclicity.
Aboubakr Elnashar
•Endocrine changes:
1. An elevated FSH level is the first measurable sign
of reproductive aging. This initial elevation in FSH
level is most prominent in the early follicular phase of
the cycle (between D2 and 5) The initial elevation in
the late reproductive stage -3 is subtle; while clinicians
often use 10 mIU/mL as the cutoff value.
Aboubakr Elnashar
2. Estradiol:
FSH level should only be interpreted in the context of
a simultaneously measured E2.
In the late reproductive stage (stage -3), E2 level in the
early follicular phase is either normal or elevated. If it
is elevated, it can suppress what otherwise would be
an elevated FSH level
An E2 level 80 pg/ml is often considered to be
elevated.
Aboubakr Elnashar
Aboubakr Elnashar
•Menopause
The anchor point that is defined after 12 months of
amenorrhea following the FMP (Retrospective diagnosis)
•Perimenopause:
Literally means “about or around the menopause.” It begins at
the same time as the MT i.e. with stage -2 and ends 12 months
after the FMP.
•The climacteric
is a vague term that used synonymously with perimenopause.
The terms perimenopause and climacteric should be used only
with patients and in the lay press and not in scientific papers.
Aboubakr Elnashar
Menopausal transition (MT):
Stage -2 (early) and -1 (late)
The MT
begins with variation in menstrual cycle length in a woman
who has a monotropic FSH rise &
ends with the FMP
The early MT (stage -2):
Menstrual cycles remain regular, but the duration changes by 7
days or more.
The late MT (stage-1):
2 or more skipped menstrual periods & at least one
intermenstrual interval of 60 days or more.
Aboubakr Elnashar
Aboubakr Elnashar
Endocrine changes in MT:
1. FSH levels gradually increase throughout MT, but
levels vary greatly.
FSH levels can vary from cycle to cycle & can be
falsely reassuring if they are low.
The increase in FSH early in MT is due to increased
negative feedback effects on the hypothalamus &
pituitary.
These effects may be reduced because of a decrease in
an ovarian inhibin factor rather than E2, as
previously believed.
Aboubakr Elnashar
2. Estradiol:
Recent investigations suggest that a progressive, linear decline
in estrogen secretion does not occur during the MT.
In MT stage, the elevated FSH levels may lead to increased E2
production greater than seen in women under the age of 35
years (Santro et al, 1996).
3. Inhibin & activin:
A combination of decreased inhibin A & B & increased activin
may favor greater output of FSH in the absence of any
decrease (& perhaps an increase) in E2 production
Aboubakr Elnashar
Aboubakr Elnashar
Symptoms of MT
Early:
• Cycle irregularity
• Vasomotor symptoms, breast tenderness, insomnia,
migraines, and premenstrual dysphoria.
Late:
• Genital atrophic symptoms
• Problems in sexual function
Aboubakr Elnashar
Ovarian sonography in MT
1. The number of antral follicle (2–10 mm)
-Does not vary over the menstrual cycle
-Correlates well with chronological age
-Before the age of 37 years, the antral follicle count
showed a mean yearly decline of 4.8%, compared
with 11.7% thereafter (Scheffer et al,1999).
-Clearly related to reproductive age and reflect the size
of the remaining primordial follicle pool.
Aboubakr Elnashar
2. Ovarian volume:
•A strong direct relationship between ovarian volume
and the number of primordial follicles remaining in
the ovaries.
•Follicle decline with age
Wallace & Kelsey (Drs of Computer Sciences),
developed a technique for measuring a woman’s
‘bioclock’ (Hum Rep, 2004).
They applied mathematical and computer
models/analysis to find out the follicle population
decline for women entering the menopause early or
late
Aboubakr Elnashar
•The measurement of ovarian volume by TVS will
enable
1. An accurate prediction of the age of menopause and
hence a woman’s reproductive age.
2. Estimate accurately how many follicles are left and
therefore what is the woman’s ‘reproductive age..
•Assisted conception,
•Treatment for childhood cancer and
•women who may want to delay a family for personal
or professional reasons.
Aboubakr Elnashar
Aboubakr Elnashar
Stage +1 (early) postmenopause
defined as 5 years since the FMP. Stage +1 was further
subdivided into
segment “a”, the first 12 months after the FMP, and
segment “b”, the next 4 years.
Stage +2 (late postmenopause) has a definite
beginning but its duration varies, since it ends with
death.
Aboubakr Elnashar
Aboubakr Elnashar
Aboubakr Elnashar
1. Stages of reproductive aging are seven:
Five stages precede and two follow the final menstrual
period.
Stages -5 to -3 encompass the reproductive interval;
Stages -2 and -1 are the menopausal transition; and
Stages +1 and +2 are the postmenopause.
2. The reproductive staging system is a distinct
improvement in reproductive health.
3. These definitions are currently the best description
of reproductive aging but are subject to modification
as more knowledge becomes available
Aboubakr Elnashar
Aboubakr Elnashar

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Diagnosis and management of male infertility
Diagnosis and management of male infertilityDiagnosis and management of male infertility
Diagnosis and management of male infertility
 
Physiology of Menstrual Cycle
Physiology of Menstrual CyclePhysiology of Menstrual Cycle
Physiology of Menstrual Cycle
 
Menopause
Menopause Menopause
Menopause
 
HORMONAL CONTROL OF TESTICULAR FUNCTION
HORMONAL CONTROL OF TESTICULAR FUNCTIONHORMONAL CONTROL OF TESTICULAR FUNCTION
HORMONAL CONTROL OF TESTICULAR FUNCTION
 
Puberty.ppt
Puberty.pptPuberty.ppt
Puberty.ppt
 
Precocious puberty
Precocious pubertyPrecocious puberty
Precocious puberty
 
Menopause by Dr Shahjada Selim
Menopause by Dr Shahjada SelimMenopause by Dr Shahjada Selim
Menopause by Dr Shahjada Selim
 
Reproductive Endocrinology
Reproductive EndocrinologyReproductive Endocrinology
Reproductive Endocrinology
 
Oocyte retrival
Oocyte retrivalOocyte retrival
Oocyte retrival
 
Physiology of Parturition & Lactation
Physiology of Parturition & LactationPhysiology of Parturition & Lactation
Physiology of Parturition & Lactation
 
Management of Male Infertility
Management of Male InfertilityManagement of Male Infertility
Management of Male Infertility
 
Sexual Differentiation (Learn easy way)
Sexual Differentiation (Learn easy way)Sexual Differentiation (Learn easy way)
Sexual Differentiation (Learn easy way)
 
Puberty
PubertyPuberty
Puberty
 
Female sexual dysfunction
Female sexual dysfunction Female sexual dysfunction
Female sexual dysfunction
 
Control mechanism of Female Reproduction
 Control mechanism of Female Reproduction Control mechanism of Female Reproduction
Control mechanism of Female Reproduction
 
Teratology
TeratologyTeratology
Teratology
 
menopause geet..pptx
menopause geet..pptxmenopause geet..pptx
menopause geet..pptx
 
Sperm Count Management
Sperm Count ManagementSperm Count Management
Sperm Count Management
 
Andrology.ppt
Andrology.pptAndrology.ppt
Andrology.ppt
 
Male infertility and ART techniques ,Treatments of male infertility
Male infertility and ART techniques ,Treatments of male infertilityMale infertility and ART techniques ,Treatments of male infertility
Male infertility and ART techniques ,Treatments of male infertility
 

Destacado

Management of Fetal hydrocephalus
Management of Fetal hydrocephalus Management of Fetal hydrocephalus
Management of Fetal hydrocephalus Aboubakr Elnashar
 
Management of Rh-Sensitized Pregnant Patient
Management of  Rh-Sensitized Pregnant Patient Management of  Rh-Sensitized Pregnant Patient
Management of Rh-Sensitized Pregnant Patient Aboubakr Elnashar
 
The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis
The Use of Anti-D Immunoglobulin for Rhesus D ProphylaxisThe Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis
The Use of Anti-D Immunoglobulin for Rhesus D ProphylaxisAboubakr Elnashar
 
Thrombocytopenia during pregnancy
Thrombocytopenia during pregnancyThrombocytopenia during pregnancy
Thrombocytopenia during pregnancyAboubakr Elnashar
 
Contraception for women aged over 40 years
Contraception  for women aged  over 40 yearsContraception  for women aged  over 40 years
Contraception for women aged over 40 yearsAboubakr Elnashar
 
Psychosexual dysfunction in circumcised females
Psychosexual dysfunction in circumcised femalesPsychosexual dysfunction in circumcised females
Psychosexual dysfunction in circumcised femalesAboubakr Elnashar
 
Clomiphene citrate & dexamethazone in treatment of clomiphene citrate resist...
Clomiphene citrate & dexamethazone  in treatment of clomiphene citrate resist...Clomiphene citrate & dexamethazone  in treatment of clomiphene citrate resist...
Clomiphene citrate & dexamethazone in treatment of clomiphene citrate resist...Aboubakr Elnashar
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success Aboubakr Elnashar
 
Anti D prophylaxis- Dr. Shashikala
Anti D prophylaxis- Dr. ShashikalaAnti D prophylaxis- Dr. Shashikala
Anti D prophylaxis- Dr. Shashikalaapollobgslibrary
 
Obstetric antiphospholipid antibody syndrome
Obstetric antiphospholipid  antibody syndrome Obstetric antiphospholipid  antibody syndrome
Obstetric antiphospholipid antibody syndrome Aboubakr Elnashar
 
Gynecological causes of acute abdominal pain
Gynecological causes of  acute abdominal painGynecological causes of  acute abdominal pain
Gynecological causes of acute abdominal painAboubakr Elnashar
 
Sexual Abuse Experienced by Egyptian Married Women
Sexual Abuse  Experienced by  Egyptian Married WomenSexual Abuse  Experienced by  Egyptian Married Women
Sexual Abuse Experienced by Egyptian Married WomenAboubakr Elnashar
 
Effect of sperm morphology& number on success of IUI
Effect of sperm morphology& number on success of IUIEffect of sperm morphology& number on success of IUI
Effect of sperm morphology& number on success of IUIAboubakr Elnashar
 
Rhesus Isoimmunisation
Rhesus IsoimmunisationRhesus Isoimmunisation
Rhesus Isoimmunisationlimgengyan
 

Destacado (20)

Management of Fetal hydrocephalus
Management of Fetal hydrocephalus Management of Fetal hydrocephalus
Management of Fetal hydrocephalus
 
Management of Rh-Sensitized Pregnant Patient
Management of  Rh-Sensitized Pregnant Patient Management of  Rh-Sensitized Pregnant Patient
Management of Rh-Sensitized Pregnant Patient
 
The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis
The Use of Anti-D Immunoglobulin for Rhesus D ProphylaxisThe Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis
The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis
 
Thrombocytopenia during pregnancy
Thrombocytopenia during pregnancyThrombocytopenia during pregnancy
Thrombocytopenia during pregnancy
 
Galactorrhea
GalactorrheaGalactorrhea
Galactorrhea
 
Premenstrual syndrome
Premenstrual syndromePremenstrual syndrome
Premenstrual syndrome
 
Assessment of blood loss
Assessment of blood loss Assessment of blood loss
Assessment of blood loss
 
Contraception for women aged over 40 years
Contraception  for women aged  over 40 yearsContraception  for women aged  over 40 years
Contraception for women aged over 40 years
 
Psychosexual dysfunction in circumcised females
Psychosexual dysfunction in circumcised femalesPsychosexual dysfunction in circumcised females
Psychosexual dysfunction in circumcised females
 
Clomiphene citrate & dexamethazone in treatment of clomiphene citrate resist...
Clomiphene citrate & dexamethazone  in treatment of clomiphene citrate resist...Clomiphene citrate & dexamethazone  in treatment of clomiphene citrate resist...
Clomiphene citrate & dexamethazone in treatment of clomiphene citrate resist...
 
Shoulder dystocia
Shoulder dystociaShoulder dystocia
Shoulder dystocia
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success
 
Anti D prophylaxis- Dr. Shashikala
Anti D prophylaxis- Dr. ShashikalaAnti D prophylaxis- Dr. Shashikala
Anti D prophylaxis- Dr. Shashikala
 
Obstetric antiphospholipid antibody syndrome
Obstetric antiphospholipid  antibody syndrome Obstetric antiphospholipid  antibody syndrome
Obstetric antiphospholipid antibody syndrome
 
Gynecological causes of acute abdominal pain
Gynecological causes of  acute abdominal painGynecological causes of  acute abdominal pain
Gynecological causes of acute abdominal pain
 
Decreased foetal movements
Decreased foetal movementsDecreased foetal movements
Decreased foetal movements
 
Sexual Abuse Experienced by Egyptian Married Women
Sexual Abuse  Experienced by  Egyptian Married WomenSexual Abuse  Experienced by  Egyptian Married Women
Sexual Abuse Experienced by Egyptian Married Women
 
Treatment of OHSS
Treatment of OHSSTreatment of OHSS
Treatment of OHSS
 
Effect of sperm morphology& number on success of IUI
Effect of sperm morphology& number on success of IUIEffect of sperm morphology& number on success of IUI
Effect of sperm morphology& number on success of IUI
 
Rhesus Isoimmunisation
Rhesus IsoimmunisationRhesus Isoimmunisation
Rhesus Isoimmunisation
 

Similar a Benha University Hospital Reproductive Aging Expert Defines Stages

Advanced reproductive age and fertility by Dr. Gayathiri
Advanced reproductive age and fertility by Dr. GayathiriAdvanced reproductive age and fertility by Dr. Gayathiri
Advanced reproductive age and fertility by Dr. GayathiriMorris Jawahar
 
Fertility.pptx
Fertility.pptx Fertility.pptx
Fertility.pptx Smawi GH
 
Optimizing natural fertility
Optimizing natural fertilityOptimizing natural fertility
Optimizing natural fertilityAboubakr Elnashar
 
Early Ovarian Aging - Dr Dhorepatil Bharati
Early Ovarian Aging - Dr Dhorepatil BharatiEarly Ovarian Aging - Dr Dhorepatil Bharati
Early Ovarian Aging - Dr Dhorepatil BharatiBharati Dhorepatil
 
Management of menopause
Management of menopauseManagement of menopause
Management of menopauseAmir Mahmoud
 
Ovarian age and reproduction. An appraisal of diagnostic methods.
Ovarian age and reproduction. An appraisal of diagnostic methods.Ovarian age and reproduction. An appraisal of diagnostic methods.
Ovarian age and reproduction. An appraisal of diagnostic methods.Mahmoud Abdel-Aleem
 
Unexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil BharatiUnexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil BharatiBharati Dhorepatil
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiBharati Dhorepatil
 
inde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.pptinde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.pptSudha Sudha
 
Menstrual Physiology - Stanford Ob-Gyn Dept
Menstrual Physiology - Stanford Ob-Gyn DeptMenstrual Physiology - Stanford Ob-Gyn Dept
Menstrual Physiology - Stanford Ob-Gyn Depthomeboundsoldier
 
Ovarianreservepamphlet4
Ovarianreservepamphlet4Ovarianreservepamphlet4
Ovarianreservepamphlet4aleeoc
 
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...Lifecare Centre
 
ART: Factors affecting success: ABOUBAKR ELNASHAR
ART: Factors affecting success: ABOUBAKR ELNASHAR ART: Factors affecting success: ABOUBAKR ELNASHAR
ART: Factors affecting success: ABOUBAKR ELNASHAR Aboubakr Elnashar
 
Catemenial epilepsy
Catemenial epilepsyCatemenial epilepsy
Catemenial epilepsySamir Mounir
 
Management of menopause
Management of menopauseManagement of menopause
Management of menopauseAmir Mahmoud
 

Similar a Benha University Hospital Reproductive Aging Expert Defines Stages (20)

Advanced reproductive age and fertility by Dr. Gayathiri
Advanced reproductive age and fertility by Dr. GayathiriAdvanced reproductive age and fertility by Dr. Gayathiri
Advanced reproductive age and fertility by Dr. Gayathiri
 
Fertility.pptx
Fertility.pptx Fertility.pptx
Fertility.pptx
 
OVARIAN RESERVE
OVARIAN RESERVEOVARIAN RESERVE
OVARIAN RESERVE
 
Menopause
MenopauseMenopause
Menopause
 
Optimizing natural fertility
Optimizing natural fertilityOptimizing natural fertility
Optimizing natural fertility
 
Early Ovarian Aging - Dr Dhorepatil Bharati
Early Ovarian Aging - Dr Dhorepatil BharatiEarly Ovarian Aging - Dr Dhorepatil Bharati
Early Ovarian Aging - Dr Dhorepatil Bharati
 
Management of menopause
Management of menopauseManagement of menopause
Management of menopause
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
 
Ovarian age and reproduction. An appraisal of diagnostic methods.
Ovarian age and reproduction. An appraisal of diagnostic methods.Ovarian age and reproduction. An appraisal of diagnostic methods.
Ovarian age and reproduction. An appraisal of diagnostic methods.
 
Unexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil BharatiUnexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil Bharati
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil Bharati
 
inde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.pptinde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.ppt
 
Menstrual Physiology - Stanford Ob-Gyn Dept
Menstrual Physiology - Stanford Ob-Gyn DeptMenstrual Physiology - Stanford Ob-Gyn Dept
Menstrual Physiology - Stanford Ob-Gyn Dept
 
Endometrial recptivity
Endometrial recptivityEndometrial recptivity
Endometrial recptivity
 
Ovarianreservepamphlet4
Ovarianreservepamphlet4Ovarianreservepamphlet4
Ovarianreservepamphlet4
 
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
 
ART: Factors affecting success: ABOUBAKR ELNASHAR
ART: Factors affecting success: ABOUBAKR ELNASHAR ART: Factors affecting success: ABOUBAKR ELNASHAR
ART: Factors affecting success: ABOUBAKR ELNASHAR
 
INFERTILITY.pptx
INFERTILITY.pptxINFERTILITY.pptx
INFERTILITY.pptx
 
Catemenial epilepsy
Catemenial epilepsyCatemenial epilepsy
Catemenial epilepsy
 
Management of menopause
Management of menopauseManagement of menopause
Management of menopause
 

Más de Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 

Más de Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Último

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 

Último (20)

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 

Benha University Hospital Reproductive Aging Expert Defines Stages

  • 1. Benha University Hospital, Egypt Email:elnashar1953@yahoo.com Aboubakr Elnashar
  • 3. •While there is a useful staging system for puberty (Tanner/Marshall system), a similar staging system for late reproductive function has not been developed. •Confusion & duplication in the nomenclature of the reproductive aging e.g. climactric, perimenopause Aboubakr Elnashar
  • 4. •The American Society for Reproductive Medicine (ASRM) •The National Institute on Aging (NIA) •The North American Menopause Society (NAMS) Cosponsored a workshop to •develop a relevant & useful staging system •revise the nomenclature Aboubakr Elnashar
  • 5. Definition Aging: The natural progression of changes in structure and function that occur with the passage of time in the absence of known disease. Reproductive aging: •A natural process that begins at birth and proceeds as a continuum. •It is a process and not an event, and the end (menopause) is much easier to define than the beginning. Chronological age is a very poor indicator of reproductive aging. Aboubakr Elnashar
  • 6. Etiology •Oocyte depletion in the ovary. •Reproductive aging consists of a steady loss of oocytes through atresia or ovulation, which does not necessarily occur at a constant rate. •The relatively wide age range (42–58 years) for menopause in normal women indicate that either - Wide variation in number of follicles at birth or -Wide variation in the rate of oocyte loss Aboubakr Elnashar
  • 7. The workshop concentrated on developing a staging system for all healthy women who age spontaneously to a natural menopause. The purpose of a staging system To identify what point a given woman has reached in the process of reproductive aging. Aboubakr Elnashar
  • 8. The anchor for the staging system is the final menstrual period (FMP). The staging system has 7 stages; 5 precede and 2 follow the final menstrual period. Stages -5 to -3 encompass the reproductive interval; Stages -2 and -1 are the menopausal transition; and Stages +1 and +2 are the postmenopause. Aboubakr Elnashar
  • 11. There is no demarcation between stages -5 to -3, since fertility increases & decreases gradually over many years. Menstrual cycles: After menarche (entry into stage -5) it usually takes several years for regular menstrual cycles to become established. Menstrual periods should then occur every 21 to 35 days for a number of years (stages -4 & -3). Aboubakr Elnashar
  • 12. Fertility: •A woman’s peak fertility occurs in her mid- to late twenties, after which it progressively decreases until menopause (stage -4 to -1). •Loss of fertility is the first sign of reproductive aging that precedes the monotropic increase in FSH and changes in menstrual cyclicity. Aboubakr Elnashar
  • 13. •Endocrine changes: 1. An elevated FSH level is the first measurable sign of reproductive aging. This initial elevation in FSH level is most prominent in the early follicular phase of the cycle (between D2 and 5) The initial elevation in the late reproductive stage -3 is subtle; while clinicians often use 10 mIU/mL as the cutoff value. Aboubakr Elnashar
  • 14. 2. Estradiol: FSH level should only be interpreted in the context of a simultaneously measured E2. In the late reproductive stage (stage -3), E2 level in the early follicular phase is either normal or elevated. If it is elevated, it can suppress what otherwise would be an elevated FSH level An E2 level 80 pg/ml is often considered to be elevated. Aboubakr Elnashar
  • 16. •Menopause The anchor point that is defined after 12 months of amenorrhea following the FMP (Retrospective diagnosis) •Perimenopause: Literally means “about or around the menopause.” It begins at the same time as the MT i.e. with stage -2 and ends 12 months after the FMP. •The climacteric is a vague term that used synonymously with perimenopause. The terms perimenopause and climacteric should be used only with patients and in the lay press and not in scientific papers. Aboubakr Elnashar
  • 17. Menopausal transition (MT): Stage -2 (early) and -1 (late) The MT begins with variation in menstrual cycle length in a woman who has a monotropic FSH rise & ends with the FMP The early MT (stage -2): Menstrual cycles remain regular, but the duration changes by 7 days or more. The late MT (stage-1): 2 or more skipped menstrual periods & at least one intermenstrual interval of 60 days or more. Aboubakr Elnashar
  • 19. Endocrine changes in MT: 1. FSH levels gradually increase throughout MT, but levels vary greatly. FSH levels can vary from cycle to cycle & can be falsely reassuring if they are low. The increase in FSH early in MT is due to increased negative feedback effects on the hypothalamus & pituitary. These effects may be reduced because of a decrease in an ovarian inhibin factor rather than E2, as previously believed. Aboubakr Elnashar
  • 20. 2. Estradiol: Recent investigations suggest that a progressive, linear decline in estrogen secretion does not occur during the MT. In MT stage, the elevated FSH levels may lead to increased E2 production greater than seen in women under the age of 35 years (Santro et al, 1996). 3. Inhibin & activin: A combination of decreased inhibin A & B & increased activin may favor greater output of FSH in the absence of any decrease (& perhaps an increase) in E2 production Aboubakr Elnashar
  • 22. Symptoms of MT Early: • Cycle irregularity • Vasomotor symptoms, breast tenderness, insomnia, migraines, and premenstrual dysphoria. Late: • Genital atrophic symptoms • Problems in sexual function Aboubakr Elnashar
  • 23. Ovarian sonography in MT 1. The number of antral follicle (2–10 mm) -Does not vary over the menstrual cycle -Correlates well with chronological age -Before the age of 37 years, the antral follicle count showed a mean yearly decline of 4.8%, compared with 11.7% thereafter (Scheffer et al,1999). -Clearly related to reproductive age and reflect the size of the remaining primordial follicle pool. Aboubakr Elnashar
  • 24. 2. Ovarian volume: •A strong direct relationship between ovarian volume and the number of primordial follicles remaining in the ovaries. •Follicle decline with age Wallace & Kelsey (Drs of Computer Sciences), developed a technique for measuring a woman’s ‘bioclock’ (Hum Rep, 2004). They applied mathematical and computer models/analysis to find out the follicle population decline for women entering the menopause early or late Aboubakr Elnashar
  • 25. •The measurement of ovarian volume by TVS will enable 1. An accurate prediction of the age of menopause and hence a woman’s reproductive age. 2. Estimate accurately how many follicles are left and therefore what is the woman’s ‘reproductive age.. •Assisted conception, •Treatment for childhood cancer and •women who may want to delay a family for personal or professional reasons. Aboubakr Elnashar
  • 27. Stage +1 (early) postmenopause defined as 5 years since the FMP. Stage +1 was further subdivided into segment “a”, the first 12 months after the FMP, and segment “b”, the next 4 years. Stage +2 (late postmenopause) has a definite beginning but its duration varies, since it ends with death. Aboubakr Elnashar
  • 30. 1. Stages of reproductive aging are seven: Five stages precede and two follow the final menstrual period. Stages -5 to -3 encompass the reproductive interval; Stages -2 and -1 are the menopausal transition; and Stages +1 and +2 are the postmenopause. 2. The reproductive staging system is a distinct improvement in reproductive health. 3. These definitions are currently the best description of reproductive aging but are subject to modification as more knowledge becomes available Aboubakr Elnashar